SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID booster shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new booster vaccine (PHH-1V81) against COVID-19 in 913 adults who had already received mRNA vaccines. The goal was to see if it is safe and boosts the immune system against newer virus variants. Participants received either the new vaccine or an existing one, …
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:06 UTC
-
Could an old depression drug help fight COVID-19? new study explores immune effects
Knowledge-focused CompletedThis study looked at how phenelzine, a drug used for depression, changes immune cells in people with COVID-19. Researchers measured activation of T cells and monocytes in blood samples from 51 patients. The goal was to understand the drug's effect on the immune system, not to tre…
Matched conditions: SARS-COV2 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 05:56 UTC
-
Massive study tracks 15,000 adults to uncover long COVID mysteries
Knowledge-focused CompletedThis study followed over 15,000 adults with and without COVID-19 to learn why some people develop long-term symptoms (Long COVID). Researchers collected health data, medical records, and biological samples over time. The goal was to identify risk factors and track how common thes…
Matched conditions: SARS-COV2 INFECTION
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Paris shelter study reveals hidden COVID-19 spread among homeless
Knowledge-focused CompletedThis study looked at how many people in homeless shelters and their staff in Paris had COVID-19 during the early pandemic. Researchers tested 179 adults for antibodies to see past infections. The goal was to understand the virus's impact on a vulnerable group.
Matched conditions: SARS-COV2 INFECTION
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC